Nanoengineering of Biomaterials 2021
DOI: 10.1002/9783527832095.ch17
|View full text |Cite
|
Sign up to set email alerts
|

Nanostructured Carrageenan as Drug Carrier

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 51 publications
0
2
0
Order By: Relevance
“…These differences in release profiles could be explained by the differences in the chemical structure of each polysaccharide and coating component [ 72 ] or the formation of complexes or interactions with the active compound and the coating materials acting as retaining agents [ 73 ]. The mathematical fitting of five previously described kinetic models in this report was applied to analyze these results further.…”
Section: Discussionmentioning
confidence: 99%
“…These differences in release profiles could be explained by the differences in the chemical structure of each polysaccharide and coating component [ 72 ] or the formation of complexes or interactions with the active compound and the coating materials acting as retaining agents [ 73 ]. The mathematical fitting of five previously described kinetic models in this report was applied to analyze these results further.…”
Section: Discussionmentioning
confidence: 99%
“…The main types of carrageenans used in the pharmaceutical development of mucoadhesive formulations are κ-, ιand λ-carrageenan. The main differences in these carrageenans are due to the number and position of the ester sulfate groups within the galactose repeating units [51,122,123]. Carrageenans, along with alginate, hypromellose, and cellulose, are alternatives to animal gelatin in the manufacture of hard capsules [124].…”
Section: Anionic Biopolymersmentioning
confidence: 99%